{
 "name": "鴻林堂",
 "slug": "tw-7422",
 "aliases": [
  "鴻林堂生物科技股份有限公司",
  "SMOBIO",
  "7422"
 ],
 "ticker": "7422",
 "industry": "生技醫療業",
 "website": "https://tw.smobio.com",
 "summary": "鴻林堂（7422）是興櫃的生技醫療類股公司，2014 年成立，2026 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "鴻林堂生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "SMOBIO",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2026-07-24",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2014-02-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "李冠林",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "李冠林",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 232720000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安永聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://tw.smobio.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "主要產品：Protein Marker系列",
   "value": "蛋白質分子量標記；公司主力生命科學試劑",
   "unit": "",
   "as_of": "2026-07-17",
   "source": "https://mopsov.twse.com.tw/nas/STR/742220260717M001.pdf",
   "note": "2026-07-17 21:08:30公告之2026-07-20興櫃前法說附件（MOPS檔名742220260717M001.pdf）；as_of採發布公告日，非會議日。未宣稱這些研究試劑取得藥品或臨床醫材上市許可。"
  },
  {
   "claim": "主要產品：QPAGE",
   "value": "電泳預鑄膠；營銷中產品組合",
   "unit": "",
   "as_of": "2026-07-17",
   "source": "https://mopsov.twse.com.tw/nas/STR/742220260717M001.pdf",
   "note": "2026-07-17 21:08:30公告之2026-07-20興櫃前法說附件（MOPS檔名742220260717M001.pdf）；as_of採發布公告日，非會議日。未宣稱這些研究試劑取得藥品或臨床醫材上市許可。"
  },
  {
   "claim": "主要產品：DNA／RNA分子生物試劑",
   "value": "DNA／RNA類分子生物研究試劑；營銷中產品組合",
   "unit": "",
   "as_of": "2026-07-17",
   "source": "https://mopsov.twse.com.tw/nas/STR/742220260717M001.pdf",
   "note": "2026-07-17 21:08:30公告之2026-07-20興櫃前法說附件（MOPS檔名742220260717M001.pdf）；as_of採發布公告日，非會議日。未宣稱這些研究試劑取得藥品或臨床醫材上市許可。"
  },
  {
   "claim": "主要產品：RNA KIT",
   "value": "RNA合成材料與服務；已含於現有生命科學試劑銷售",
   "unit": "",
   "as_of": "2026-07-17",
   "source": "https://mopsov.twse.com.tw/nas/STR/742220260717M001.pdf",
   "note": "2026-07-17 21:08:30公告之2026-07-20興櫃前法說附件（MOPS檔名742220260717M001.pdf）；as_of採發布公告日，非會議日。未宣稱這些研究試劑取得藥品或臨床醫材上市許可。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-7422.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}